Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Cancer Res ; 62(19): 5451-6, 2002 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-12359752

RESUMO

The development of oral squamous cell carcinoma (SCC) shows a positive correlation with the carcinogen exposure that occurs during tobacco and alcohol use. The purpose of this study was to investigate whether the naturally occurring chemopreventive agent, curcumin, modulates expression and function of carcinogen- metabolizing enzymes in human keratinocytes isolated from oral SCC tumors. Dose-response studies demonstrated that curcumin concentrations of >or=25 micro M were cytotoxic for oral SCC cells. Curcumin increased both expression (reverse transcription-PCR analyses) and function (high-performance liquid chromatography determination of ethoxyresorufin metabolism) of cytochrome P-450 (CYP) 1A1 and/or CYP1B1. The aryl hydrocarbon receptor (AhR), which up-regulates a battery of genes associated with carcinogen metabolism, is activated by polycyclic aromatic hydrocarbons such as the tobacco-associated carcinogen benzo(a)pyrene. Electromobility shift assays demonstrated that similar to the established AhR ligand 2,3,7,8,-tetrachlorodibenzo-p-dioxin, curcumin inclusion resulted in AhR nuclear translocation and formation of the transcriptionally active AhR-aryl hydrocarbon receptor nuclear translocator complex. Cellular capacity to bioactivate the tobacco-associated carcinogen (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiodiol was determined by evaluating conversion of the carcinogenic metabolite diol epoxide to stable tetrols via high-performance liquid chromatography. Results of our metabolism studies showed that curcumin significantly inhibited CYP1A1-mediated benzo(a)pyrene diol bioactivation in both oral SCC cells and intact oral mucosa. Because CYP1A1 is one of the primary carcinogen-activating enzymes in oral mucosa, the use of curcumin as an oral cavity chemopreventive agent could have significant clinical impact via its ability to inhibit carcinogen bioactivation.


Assuntos
Antineoplásicos/farmacologia , Carcinógenos/farmacocinética , Carcinoma de Células Escamosas/metabolismo , Curcumina/farmacologia , Proteínas de Ligação a DNA , Di-Hidroxi-Di-Hidrobenzopirenos/farmacocinética , Mucosa Bucal/metabolismo , Neoplasias Bucais/metabolismo , Receptores de Hidrocarboneto Arílico/metabolismo , Adulto , Idoso , Hidrocarboneto de Aril Hidroxilases/metabolismo , Translocador Nuclear Receptor Aril Hidrocarboneto , Biotransformação/efeitos dos fármacos , Carcinógenos/antagonistas & inibidores , Carcinoma de Células Escamosas/induzido quimicamente , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/enzimologia , Divisão Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Citocromo P-450 CYP1A1/antagonistas & inibidores , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP1B1 , Di-Hidroxi-Di-Hidrobenzopirenos/antagonistas & inibidores , Glutationa/metabolismo , Humanos , Queratinócitos/efeitos dos fármacos , Queratinócitos/enzimologia , Queratinócitos/metabolismo , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/efeitos dos fármacos , Mucosa Bucal/enzimologia , Neoplasias Bucais/induzido quimicamente , Neoplasias Bucais/tratamento farmacológico , Neoplasias Bucais/enzimologia , Oxazinas/metabolismo , Fatores de Transcrição/metabolismo , Células Tumorais Cultivadas
2.
Toxicol Lett ; 158(1): 50-60, 2005 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-15993743

RESUMO

Sanguinarine's use in human clinical applications is currently controversial. While some studies have demonstrated sanguinarine's anti-inflammatory and anti-oxidant properties, other investigations reported sanguinarine's procarcinogenic effects. Like the tobacco-associated carcinogen, benzo(a)pyrene (B(a)P), sanguinarine is a polycyclic aromatic hydrocarbon (PAH). PAH exposure activates the aryl hydrocarbon transcription activating factor (AhR), resulting in nuclear translocation, binding to the aryl hydrocarbon nuclear translocator (ARNT), which thereby increases expression of a pool of carcinogen metabolizing enzymes. The goal of this study was to investigate whether sanguinarine activates this PAH-associated signaling cascade in human oral cells and tissues. Our results demonstrate that sanguinarine: (i) results in formation of the AhR-ARNT complex, (ii) induces AhR-associated gene expression, (iii) inhibits cytochrome P450 1A1 (CYP 1A1) microsomal oxidative activity and (iv) pretreatment upregulates CYP 1A1 function. Collectively, these data provide evidence that sanguinarine activates PAH-associated signaling and metabolic pathways. Notably, previous studies have demonstrated that mammalian hepatic microsomes metabolize sanguinarine to a mutagenic epoxide. Persons who respond to sanguinarine exposure with induction of primarily Phase I relative to Phase II enzymes are, therefore, at risk for sanguinarine bioactivation and its potential mutagenic effects.


Assuntos
Alcaloides/toxicidade , Hidrocarboneto de Aril Hidroxilases/biossíntese , Proteínas de Ligação a DNA/biossíntese , Queratinócitos/enzimologia , Mucosa Bucal/enzimologia , Antissépticos Bucais/toxicidade , Fenantridinas/toxicidade , Receptores de Hidrocarboneto Arílico/biossíntese , Fatores de Transcrição/biossíntese , Adulto , Idoso , Hidrocarboneto de Aril Hidroxilases/antagonistas & inibidores , Hidrocarboneto de Aril Hidroxilases/genética , Translocador Nuclear Receptor Aril Hidrocarboneto , Benzo(a)pireno/metabolismo , Benzofenantridinas , Carcinógenos/metabolismo , Linhagem Celular Tumoral , Citocromo P-450 CYP1A1/antagonistas & inibidores , Citocromo P-450 CYP1A1/biossíntese , Citocromo P-450 CYP1A1/genética , Citocromo P-450 CYP1B1 , Proteínas de Ligação a DNA/genética , Relação Dose-Resposta a Droga , Indução Enzimática/efeitos dos fármacos , Humanos , Isoquinolinas , Queratinócitos/efeitos dos fármacos , Queratinócitos/patologia , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/efeitos dos fármacos , Mucosa Bucal/patologia , Receptores de Hidrocarboneto Arílico/genética , Fatores de Transcrição/genética , Regulação para Cima/efeitos dos fármacos
3.
Pharm Res ; 26(4): 977-86, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19137418

RESUMO

PURPOSE: Results from our oral cavity chemoprevention trial demonstrated appreciable interpatient variations regarding chemopreventive efficacy of a freeze dried black raspberry (FBR) gel. We speculated these data reflected individual patient-related differences in absorption, target tissue uptake and local compound metabolism of key FBR compounds (anthocyanins). Accordingly, this study assessed the distribution of anthocyanins from the 10% (w/w) FBR gel in saliva, oral tissues and plasma. METHODS: Human subject participation entailed collection of: (1) saliva, tissue and plasma (5 min following gel application, keratinized tissues), (2) saliva and plasma (5 min after sublingual gel application), (3) saliva and plasma at 1, 2, and 4 h post gel application (keratinized tissues), and (4) saliva (cyanidin 3-rutinoside incubations). Levels of FBR anthocyanins in the respective samples were analyzed by LC/MS/MS. RESULTS: Our data show: significantly higher anthocyanin levels in saliva and oral tissues relative to matched plasma samples, marked donor-specific variations in anthocyanin uptake, sustainability of anthocyanins at the target site, pH affects anthocyanin penetration and intraoral anthocyanin decomposition and/or metabolism. CONCLUSIONS: No previous oral cavity chemoprevention trials evaluated compound distribution at the treatment site. Our data, which demonstrate a local delivery-derived pharmacologic advantage, provide insights which could advance oral cavity chemoprevention strategies.


Assuntos
Antocianinas/farmacocinética , Anticarcinógenos/farmacocinética , Boca/metabolismo , Rosaceae , Saliva/metabolismo , Adesividade , Administração Oral , Administração Tópica , Adolescente , Adulto , Antocianinas/administração & dosagem , Antocianinas/sangue , Antocianinas/química , Anticarcinógenos/administração & dosagem , Anticarcinógenos/sangue , Anticarcinógenos/química , Biotransformação , Cromatografia Líquida , Feminino , Géis , Humanos , Masculino , Procedimentos Cirúrgicos Bucais , Preparações de Plantas/farmacocinética , Espectrometria de Massas em Tandem , Distribuição Tecidual , Adulto Jovem
4.
Pharm Res ; 24(4): 728-37, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17372698

RESUMO

PURPOSE: The purpose of these studies was to formulate mucoadhesive gels containing freeze dried black raspberries (FBR) and to determine optimum parameters for a subset of FBR bioactive compounds including anthocyanin stability, absorption and penetration in-vitro and in-vivo. MATERIALS AND METHODS: Berry gels were prepared having FBR at 5% and 10% w/w and final pHs ranging from 3.5 to 7.5. A HPLC assay was developed to quantify and determine the stability of the anthocyanins in the gels. A single time-point study was performed to determine anthocyanin uptake when the gels were applied to oral mucosa. Penetration of anthocyanins into human oral tissue explants was determined as a function of gel pH and FBR content. A HPLC-mass spectroscopy assay was utilized to quantify the anthocyanin levels in human oral tissue explants, saliva, and blood. RESULTS: The stability of anthocyanins in the gel was directly related to gel pH and storage temperature. Maximum stability of anthocyanins was found at lower pH (pH 3.5) and storage temperature (4 degrees C). Anthocyanins contained in mucoadhesive berry gel formulations were readily absorbed into human oral mucosa tissue as evidenced by detectable blood levels within 5 min after gel application. There was a trend for greater penetration of anthocyanins into tissue explants for berry gels with a final pH of 6.5 versus pH 3.5. CONCLUSIONS: Formulation and characterization of a novel gel formulation for local delivery of chemopreventive compounds to human oral mucosal tissues has been described. The results show anthocyanin stability was dependent upon gel pH and storage temperature and also demonstrate that the gel composition is well-suited for absorption and penetration into the target oral mucosal tissue site.


Assuntos
Antocianinas/química , Anticarcinógenos/química , Géis , Neoplasias Bucais/prevenção & controle , Mucinas/química , Rosaceae , Adesividade , Antocianinas/análise , Antocianinas/sangue , Antocianinas/farmacocinética , Antocianinas/uso terapêutico , Anticarcinógenos/sangue , Anticarcinógenos/farmacocinética , Anticarcinógenos/uso terapêutico , Química Farmacêutica , Cromatografia Líquida de Alta Pressão/métodos , Estabilidade de Medicamentos , Liofilização , Frutas , Humanos , Concentração de Íons de Hidrogênio , Espectrometria de Massas , Mucosa Bucal/metabolismo , Extratos Vegetais/química , Reprodutibilidade dos Testes , Saliva/metabolismo , Tecnologia Farmacêutica , Temperatura , Técnicas de Cultura de Tecidos
5.
Nutr Cancer ; 54(1): 58-68, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16800773

RESUMO

Despite focused efforts to improve therapy, 5-yr survival rates for persons with advanced-stage oral squamous cell carcinoma (SCC) remain discouragingly low. Clearly, early detection combined with strategies for local intervention, such as chemoprevention prior to SCC development, could dramatically improve clinical outcomes. Previously conducted oral cavity human chemoprevention trials, however, have provided mixed results. Although some therapies showed efficacy, they were often accompanied by either significant toxicities or circulating antiadenoviral antibodies. It is clearly apparent that identification of nontoxic, effective treatments is essential to prevent malignant transformation of oral epithelial dysplasias. This study employed cell lines isolated from human oral SCC tumors to investigate the effects of a freeze-dried black raspberry ethanol extract (RO-ET) on cellular growth characteristics often associated with a transformed phenotype such as sustained proliferation, induction of angiogenesis, and production of high levels of reactive species. Our results demonstrate that RO-ET suppresses cell proliferation without perturbing viability, inhibits translation of the complete angiogenic cytokine vascular endothelial growth factor, suppresses nitric oxide synthase activity, and induces both apoptosis and terminal differentiation. These data imply that RO-ET is a promising candidate for use as a chemopreventive agent in persons with oral epithelial dysplasia.


Assuntos
Carcinoma de Células Escamosas/prevenção & controle , Conservação de Alimentos , Frutas/química , Neoplasias Bucais/prevenção & controle , Extratos Vegetais/farmacologia , Rosaceae/química , Adulto , Idoso , Carcinoma de Células Escamosas/patologia , Caspase 3 , Caspases/metabolismo , Divisão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Quimioprevenção , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Etanol , Liofilização , Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/patologia , Óxido Nítrico Sintase/antagonistas & inibidores , Fenótipo , Fitoterapia , Transglutaminases/metabolismo , Fator A de Crescimento do Endotélio Vascular/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA